AMAmalia Monroy-Ostria

Amalia Monroy-Ostria

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amalia Monroy-Ostria has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    NRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis

    by Mirsha Pamela Hernández-Rivera, Alicia Ramírez-Ramírez, Adelaido Chiñas-Pérez, Amalia Monroy-Ostria, Mario Eugenio Cancino-Díaz, Omar Hernández-Montes

    Cutaneous leishmaniasis (CL) is endemic in Campeche state, Mexico. Host and parasite factors are involved in the establishment and development of CL. Host factors include immune response and genetic background. NRAMP1 (Natural Resistance Associated Macrophage Protein 1) is important in innate immunity. Polymorphisms inNRAMP1have been associated with susceptibility or resistance to infectious and autoimmune diseases. To study the association ofNRAMP1mutations with CL in patients from Calakmul, Campeche, samples from 115 CL patients and 69 samples of healthy people from the same area were evaluated. Five regions inNRAMP1were amplified and digested, looking for mutations in the promoter region (−524G/C), exon 3 (274C/T), exon 8 (823 C7T), and exon 15 (G/A) and deletion of 4 bp in the 3′UTR region. We found a statistical association between polymorphisms in 3′UTR region and exon 8 and CL [χ2=13.26;p<0.05; OR = 17.00; IC of 95% (2.24–128.99)]. Some patients who needed more than 40 doses of Glucantime®to heal injuries presented mutations in exons 3, 8, and 15. Multiple or ear lesions were not associated withNRAMP1polymorphism.


  • Protection of rats against malaria by a transplanted immune spleen

    by Luis Favila‐Castillo, Amalia Monroy‐Ostria, Eiji Kobayashi, Chakrit Hirunpetchara T, Naoshi Kamada, Michael F. Good

    A number of reports have suggested that the spleen plays a key role in the regulation of immunity to malaria but the role, if any, of other tissues is less clear. Furthermore, numerous functional changes occur in the spleen following malaria infection and it is not known whether the spleen’s role relates primarily to its content of malaria‐specific lymphocytes or to the altered structure and function that has occurred. To address these issues we have generated splenic chimeras by transplanting spleens between Plasmodium berghei‐immune and naive rats. In the absence of a functional spleen, specific immune responses from both isolated splenic and non‐splenic cells can partially control infection. However, an immune spleen in a naive rat can solidly protect the animal from malaria and a normal spleen in an otherwise immune rat can provide enhanced protection over the non‐splenic state. Thus, in the presence of functional splenic architecture both splenic and non‐splenic malaria‐specific lymphocytes operate more effectively. However, these studies do demonstrate an important role for non‐splenic tissue in immunity at least for P. berghei in the rat. The study could have important implications for induction of protective immune responses by vaccination and suggests that malaria‐specific lymphocyte responses induced in the periphery following vaccination could interact with parasites in both spleen‐dependent and spleen‐independent ways.